Top Markets
#1 MowCat MowCat +806.52%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.27%
#3 SODAX SODAX +49.21%
#4 Cortex Cortex +27.15%
#5 Magma Finance Magma Finance +20.46%
#6 Pons Pons +19.72%
#7 Akedo Akedo +18.11%
#8 OpenEden OpenEden +14.22%
#9 MANTRA MANTRA +12.93%
#10 APEX APEX +12.08%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Mezzion Pharma Co.,Ltd. Mezzion Pharma Co.,Ltd.

Mezzion Pharma Co.,Ltd.

140410
Rank in Stocks #7810
Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the... Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the discovery, production, and licensing of various medical treatments. The company's therapeutic offerings target conditions such as erectile dysfunction, benign prostatic hyperplasia, and Fontan disease. Established by Park, Dong-Hyun on September 25, 2002, its corporate base is located in Seoul, South Korea.
Share Price
$47.85
Market Cap
$1.45B
Change (1 day)
4.22%
Change (1 year)
63.29%
Country
KR
Trade Mezzion Pharma Co.,Ltd. (140410)

Category

Healthcare
Dividend yield history for Mezzion Pharma Co.,Ltd. (140410)
Mezzion Pharma Co.,Ltd. (stock symbol: 140410) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Mezzion Pharma Co.,Ltd. (140410) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.58%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.09%
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT